A deeper understanding of the gene regulatory networks of erythropoiesis and their interference with BG-specific gene regulation could help to shed new light on the many clinical manifestations, where ABO BG-dependent differences for the development and progression of disease, such as myocardial infarction, thrombosis and infection, are observed. The gene discussed is ABO; the disease is myocardial infarction.